5.73
price up icon2.50%   0.14
after-market Handel nachbörslich: 5.69 -0.04 -0.70%
loading

Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
37.25%
47.86
34.87 36.77 37.62 33.53
Operating Income/Loss
37.25%
-47.86
-34.87 -36.77 -37.62 -33.53
Nonoperating Income/Loss
9.01%
4.08
4.484 3.201 3.066 3.148
Income/Loss From Continuing Operations Before Tax
44.08%
-43.78
-30.39 -33.56 -34.55 -30.38
Income/Loss From Continuing Operations After Tax
44.08%
-43.78
-30.39 -33.57 -34.55 -30.38
Net Income/Loss
44.08%
-43.78
-30.39 -33.57 -34.55 -30.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.08%
85.50
85.43 5.5494 57.26 56.28
Diluted Average Shares
0.08%
85.50
85.43 5.5494 57.26 56.28
Basic Earnings Per Share
41.67%
-0.51
-0.36 -0.40 -0.60 -0.54
Diluted Earnings Per Share
41.67%
-0.51
-0.36 -0.40 -0.60 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Kapitalisierung:     |  Volumen (24h):